Todos Medical Ltd. Financing Cash Flow
Todos Medical Ltd. reported Financing Cash Flow of $3.55 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-11-14
- Todos Medical Ltd. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $1.19M, a 68.20% decline year-over-year.
- Todos Medical Ltd. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $962.00K, a 79.42% decline year-over-year.
- Todos Medical Ltd. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $1.39M, a 57.43% decline year-over-year.
- Todos Medical Ltd. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $3.49M, a 86.88% increase year-over-year.
- Todos Medical Ltd. net cash provided by (used in) financing activities for fiscal 2021 was $15.18M, a 114.10% increase from fiscal 2020.
- Todos Medical Ltd. net cash provided by (used in) financing activities for fiscal 2020 was $7.09M, a 324.93% increase from fiscal 2019.
- Todos Medical Ltd. net cash provided by (used in) financing activities for fiscal 2019 was $1.67M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2022-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.15M derived: sum of 2 quarters · filed 2022-11-14 | $3.55M 10-Q · filed 2022-11-14 | $7.04M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | $962.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $2.35M 10-Q · filed 2022-08-22 | $5.84M derived: sum of 3 quarters · filed 2022-08-22 | $9.59M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-03-31 | $1.39M 10-Q · filed 2022-05-16 | $4.88M derived: sum of 2 quarters · filed 2022-05-16 | $8.63M derived: sum of 3 quarters · filed 2022-11-14 | $13.31M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $7.24M derived: sum of 2 quarters · filed 2022-11-14 | $11.91M derived: sum of 3 quarters · filed 2022-11-14 | $15.18M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $8.43M derived: sum of 2 quarters · filed 2022-11-14 | $11.70M 10-Q · filed 2022-11-14 | $13.56M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $7.94M 10-Q · filed 2022-08-22 | $9.81M derived: sum of 3 quarters · filed 2022-08-22 | $13.30M derived: sum of 4 quarters · filed 2022-08-22 | |
| 2021-03-31 | $3.27M 10-Q · filed 2022-05-16 | $5.14M derived: sum of 2 quarters · filed 2022-05-16 | $8.62M derived: sum of 3 quarters · filed 2022-05-16 | $9.63M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $5.35M derived: sum of 2 quarters · filed 2022-03-31 | $6.37M derived: sum of 3 quarters · filed 2022-03-31 | $7.09M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.50M derived: sum of 2 quarters · filed 2021-11-15 | $5.22M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24 | $1.74M 10-Q · filed 2021-09-24 | |||
| 2020-03-31 | $727.00K 10-Q · filed 2021-06-22 | ||||
| 2019-12-31 | $1.67M 10-K · filed 2021-04-21 | $1.67M 20-F · filed 2020-06-15 | |||
| 2018-12-31 | $451.26K 20-F/A · filed 2020-08-06 | ||||
| 2017-12-31 | $1.16M 20-F/A · filed 2020-08-06 | ||||
| 2016-12-31 | $787.76K 20-F · filed 2019-03-28 |